Research Article

Hydroxysafflor Yellow A Attenuates LPS-Induced Toxicity in Dopaminergic Neurons of Zebrafish by Regulating the TLR4/NF-ĸB Signaling Pathway

DOI:

10.3791/68314

July 18th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol aims to test whether hydroxysafflor yellow A (HSYA) attenuates LPS-induced neurotoxicity in zebrafish. Motor function was evaluated using a Visual Vision system. Dopaminergic nerve injury was examined by immunohistochemistry. Molecules involved in the TLR4/NF-κB pathway were analyzed using Western blot.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Lipopolysaccharide (LPS)-induced inflammation plays a crucial role in triggering and perpetuating the neurodegenerative diseases, including Parkinson's disease (PD). Hydroxysafflor yellow A (HSYA) is the main component of Carthamus tinctorius L.. This study aims to observe whether HSYA could ameliorate LPS-induced toxicity in dopaminergic neurons of zebrafish. Zebrafish were exposed to LPS and then treated with HSYA. Tests of behavior were conducted to evaluate the motor function of zebrafish. Dopaminergic neuronal injury and dopamine level were examined. TLR4, NF-κB, IL-1β, and TNF-α were also measured. It demonstrated that LPS (60 µg/mL, final concentration) induced toxicity in zebrafish and caused motor dysfunction and damage to tyrosine hydroxylase (TH)-positive neurons. LPS exposure not only decreased the content of dopamine but also increased levels of IL-1β, TNF-α, and expression of TLR4 and NF-κB. HSYA ameliorated the LPS-induced motor dysfunction. In addition, HSYA attenuated the loss of TH-positive neurons, which was accompanied by an increase in dopamine content. HSYA treatment also inhibited the expression of TLR4, NF-κB, and production of IL-1β, TNF-α. In conclusion, this study demonstrates that HSYA attenuates inflammation-induced injury in dopaminergic neurons of zebrafish by regulating the TLR4/NF-κB pathway, which provides an experimental basis for the prevention of inflammatory injury in PD.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The pathogenesis of Parkinson's disease (PD) is the deterioration of motor activity due to injury of dopaminergic neurons in the brain. The manifestations of PD include motor dysfunction, including resting tremor, bradykinesia, postural instability, and muscle tone. Inflammation is a prominent pathological hallmark of PD. Cytokine levels in cerebrospinal fluid and post-mortem nigrostriatal brain regions of individuals with PD are elevated compared with age-matched healthy controls1. The mechanisms by which dopaminergic neuronal injury is caused by inflammation have been well established. In PD, midbrain dopaminergic neurons are sensitive to cytokines such as tumor necrosis factor (TNF)-ɑ2. Lipopolysaccharide (LPS) is a component of bacteria. LPS is identified as a ligand of Toll-like receptor 4 (TLR-4). Once binding to TLR-4, LPS leads to an inflammatory response and shows toxicity to tissue. TLR-4 is located on microglia in the central nervous system. LPS activates TLR-4 and therefore produces TNF-α and IL-1β. Central or peripheral exposure to LPS will induce toxicity to the central nervous system. There is evidence demonstrating that LPS-induced toxicity plays a role in triggering and perpetuating the neurodegenerative diseases, including PD3,4,5.

Recently, zebrafish have been commonly used as a model for studying nervous system diseases. Zebrafish and humans have 80% genetic homology. And zebrafish have almost the same number of chromosomes as humans. Furthermore, the main structure of the brain of the zebrafish and its signalling pathways are similar to those of mammals. Zebrafish can also produce large numbers of transparent embryos, develop rapidly, and are prone to genetic manipulation6. These advantages make zebrafish an excellent model for investigating the pathogenesis of PD and developing high-throughput drug screening in PD.

Hydroxysafflor yellow A (HSYA) is a main ingredient of Carthamus tinctorius L. Previous studies have shown that HSYA has anti-inflammatory properties. In primary mesencephalic cultures, HSYA at 20 µM to 640 µM did not show any toxicity. And HSYA concentration ranging from 40 µM to 640 µM reduced LPS-induced dopaminergic neuronal damage7. C57BL/6J mice were exposed to 6-hydroxydopamine to induce a model of PD. HSYA not only attenuates impaired neurological function but also protects dopaminergic neurons in the brain. Furthermore, HSYA reduced the expression of cyclooxygenase-2, inducible nitric oxide synthase, and NF-κB in the substantia nigra8.

To date, there are no reports demonstrating the property of HSYA to reduce the toxicity of LPS in vivo. It showed that HSYA attenuated the LPS-induced toxicity in vitro7. However, cell-based evaluation does not represent all steps of the complex process of neurotoxicity. Zebrafish prove particularly valuable for unravelling the mechanism of toxicity. In recent years, it has also been shown that HSYA is able to inhibit NF-κB inflammatory pathway activation by decreasing the expression of protein kinase B, thereby ameliorating the inflammatory response, and that HSYA also inhibits the activator protein 1-associated inflammatory signalling pathway, which affects cell proliferation and tumour necrosis factor α-induced inflammatory injury9,10. This study aims to investigate whether HYSA can ameliorate LPS-induced toxicity in dopaminergic neurons of zebrafish.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The experiments were conducted in accordance with the National Institutes of Health Guidelines for the Use of Laboratory Animals (Publication 86-23, revised in 1986). And this study was approved by the Animal Care and Use Committee of Yantai University (YTDX20220623). The reagents and the equipment used in this study are listed in the Table of Materials.

1. Maintenance of zebrafish

AB strain zebrafish (Danio rerio) were kept in a recirculating water system at a water temperature of 27-28.5 °C (pH 7.0), on a 14/10 h light/dark cycle. Zebrafish were fed twice a day with shrimp. After natural mating, fertilized embryos were collected in Petri dishes containing E3 medium with deionized water, KCl, NaCl, MgSO4·7H2O, and CaCl2.

2. LPS-induced toxicity in zebrafish

Zebrafish embryos at 24 h post-fertilization (hpf) were harvested and assigned to control and LPS groups, with 60 embryos in each group. The LPS powder was weighed and added to a certain amount of PBS (pH = 7.4) solution for dissolution, prepared as a 2 mg/mL LPS stock solution, placed in -20 °C for storage and standby. During the experiment, the LPS reserve solution was diluted to 30 µg/mL, 60 µg/mL, and 90 µg/mL of LPS solution. LPS solution at a final concentration of 30 µg/mL, 60 µg/mL, or 90 µg/mL was added to Petri dishes containing 24 hpf zebrafish embryos; the volume of solution for each experimental well was 3 mL. In the control group, zebrafish embryos were cultured in E3 medium without LPS. Petri dishes were placed in a constant temperature incubation chamber at 28 °C. Exposure to LPS was repeated following the same procedure mentioned above for five consecutive days.

3. Effect of TLR4 inhibitor on LPS-induced toxicity in zebrafish

Zebrafish embryos at 24 hpf were assigned to control, LPS, and TAK-242 groups. A number of studies have been conducted to validate the regulatory effect of TAK-242 at a final concentration of 1 µM on the regulation of the TLR4 signalling pathway, among which some studies have shown that TAK-242, by inhibiting LPS-induced cell proliferation and the release of inflammatory factors, provides a new way of solving the problems related to the reduction of glaucoma in the postoperative period11. In the TAK-242 group, TAK-242 (1 µM, final concentration) was added to a Petri dish containing 24 hpf zebrafish embryos; the volume of solution for each experimental well was 3 mL. After 30 min, LPS (60 µg/mL, final concentration) was added to induce toxicity, and LPS concentrations did not cause zebrafish mortality. Embryos in the control group were maintained in E3 medium only. Petri dishes were placed in a constant temperature incubation chamber at 28 °C. The above procedure was repeated for five consecutive days.

4. Effect of HSYA on LPS-induced toxicity in zebrafish

Zebrafish embryos at 24 hpf were assigned to control, LPS, and HSYA groups. HSYA at a final concentration of 20 µM, 40 µM, or 80 µM was added to Petri dishes containing 24 hpf zebrafish embryos; the volume of solution for each experimental well was 3 mL. After 30 min, LPS (60 µg/mL, final concentration) was added. Embryos in the control group were maintained in E3 medium only. Petri dishes were placed in a constant temperature incubation chamber at 28 °C. The above procedure was repeated for five consecutive days.

5. Behavioral evaluation

Zebrafish were transferred to the middle 60 wells of a 96-well plate, with one zebrafish larva per well. E3 culture medium (250 µL) was added to each well to allow free swimming. Locomotor activity was recorded using a vision system. Pure water was added to the dark box (30 cm × 40 cm × 60 cm), which was set to a heating state with the temperature adjusted to 28 °C.

Once the dark box temperature reached 28 °C, the 96-well plate containing zebrafish was placed inside, and the Visual Vision system was activated to record locomotor activity. A new folder was created to store the data. Homemade Video File was selected as the video source to enter the experimental settings interface. In the Experiment Settings section, the number of observation zones was set to 60, allowing simultaneous observation of 60 zebrafish. In Arena Settings, the image of the 96-well plate captured by the lens appeared on screen, along with positioning circles. The modules in the Arrange Arenas interface were adjusted so that the lens capture area aligned with each well. In Arena Hardware Mapping, the dark box light was set to Light on.

In Trial Control Settings, a new program was created with a 10 min preparation period and a 10 min detection period, which was then applied to all parallel experiments. Detection Settings was used to confirm that the lens capture function was operating normally. In Trial List, data from 60 zebrafish in each group were displayed. The number of trials in the toolbar was used to generate a data table containing all experimental groups, ensuring data completeness.

All settings were confirmed, and the dark box temperature was maintained at 28 °C. After verifying that each well contained one zebrafish with vital signs, the experiment was initiated. During the experiment, the behavioral instrument's lens recorded the movement trajectory, duration, and related parameters. After 20 min of the first recording, the system automatically ended and prepared for the next trial. The dark box was opened, and the 96-well plate was replaced with a new one containing zebrafish for the subsequent experiment.

At the end of the experiment, Results was selected from the Analysis module. Experimental parameters such as average speed, distance, maximum acceleration, and absolute steering angle were extracted from the results module and exported. The data were then compiled for analysis of behavioral differences among zebrafish groups12.

6. Measurement of pro-inflammatory cytokines

Zebrafish were collected. Specimens were weighed and PBS (0.01 M, pH = 7.4) was added at a gravimetric ratio of 1:9 and homogenised (5000 r/min, 30 s) at 4 °C. Homogenates were centrifuged at 4 °C, 5000 x g, 20 min, and supernatants were harvested. IL-1β and TNF-α were assayed with fish ELISA kits according to the instructions provided by the manufacturer.

7. Immunohistochemistry

Zebrafish were fixed with 5 mL 4% (v/v) paraformaldehyde. Embedded in paraffin and cut 5 µm-thick sections. Sections were incubated with citrate buffer (200 µL) in the microwave for 10 min. They were incubated in 0.3% hydrogen peroxide and methanol solution for 30 min to block endogenous peroxidases. Washed with PBS 3 times, 5 min each time. Non-immune serum was incubated for 30 min at 37 ºC. Primary anti-TH antibody (1:100) was incubated for 30 min at 37 ºC. Washed 3 times with PBS. Incubated with secondary antibody linked with horseradish peroxidase (1:200) at 37 ºC for 30 min. Then, 3,3´-diaminodbenzidine was added. Sections were imaged using a brightfield microscope.

8. Neurotransmitters

HPLC-ECD was employed to assay the dopamine level. Dopamine hydrochloride was dissolved in 0.1 M perchloric acid (HClO4) to obtain a concentration gradient solution at 3.90625 ng/mL, 7.8125 ng/mL, 15.625 ng/mL, 31.25 ng/mL, 62.5 ng/mL, and 125 ng/mL. A series of dopamine standard solutions was analyzed by HPLC-ECD. Linear regression was performed using dopamine concentration and dopamine peak area. A standard curve was plotted. Zebrafish tissues were homogenized with 0.1 M HClO413. Homogenates were centrifuged at 4 °C, 20,000 x g, 15 min. Next, samples were separated on an ODS2 column (E2118047; 4.6 × 250 mm, 5 µm). Buffer was prepared: 25 mmol/L sodium acetate, 25 mmol/L citric acid, 0.01 mmol/L ethylenediaminetetraacetic acid disodium salt, 1 mmol/L sodium 1-octanesulfonate, and acetic acid, pH adjusted to 3.35. The mobile phase was acetonitrile: buffer (1:9, v/v). After vacuum filtration with a 0.22 µm filter membrane, the sample was degassed by ultrasonic degassing for 10 min. The temperature of the column oven was 30 °C. The flow rate was 1 mL/min. The sample was injected at a volume of 20 µL. The electrochemical detector was operated at a voltage of 1000 mV with a 10 µA range. The amount of dopamine in zebrafish tissues was calculated based on the regression equation.

9. Western blot

Proteins were extracted from zebrafish tissue, and the concentration was assayed (final concentration: 10 mg/mL). Proteins (50 µg/5 µL) were subjected to 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The transfer membrane was conducted at 110 V for 1 h. Membranes were blocked with 5% milk for 1 h. Incubated at 4 °C with primary antibodies: rabbit anti-TLR4 (1:1000), rabbit anti-NF-κB (1:2000), rabbit anti-lamin B1 (1:2000), or rabbit anti-GAPDH (1:1000). After washing with TBST (3 times for 5 min each), the membranes were incubated with secondary antibody for 1 h. Bands were visualized using an ECL Chemiluminescent Substrate Kit and quantified using a gel imaging system. Lamin B1 and GAPDH were used as loading controls.

10. Statistical analysis

All data were expressed as mean ± SD and analyzed with statistical software. Statistical analyses were performed using one-way analysis of variance (ANOVA) followed by Tukey's test. A P-value of <0.05 was statistically significant.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Effects of LPS on the motor function of zebrafish
The mean speed, total distance, and maximum acceleration of zebrafish in the LPS (60 µg/mL and 90 µg/mL) groups were reduced (P < 0.01) compared to the control group. The motor dysfunction was also manifested as frequent changes in the direction of movement. The absolute turning angle of swimming of zebrafish in the LPS 60 µg/mL and LPS 90 µg/mL groups was significantly increased (P < 0.01) (

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Medicinal plants have a long track record of anti-inflammatory and neuroprotective applications14. Our previous studies showed that HSYA had a protective effect in neurotoxic agent-induced PD animal models. Using LPS-induced toxicity in zebrafish, this study demonstrates that HSYA attenuates the inflammation-induced injury in dopaminergic neurons of zebrafish by regulating the TLR4/NF-κB signaling pathway.

Not only are sleep disorders and cognitive dysfunction clos...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors declare no conflicts of interest.

AUTHOR CONTRIBUTION:
Conceptualization: Guirong Zhang, Bing Han. Funding acquisition: Guirong Zhang, Bing Han. Investigation: Huilin Zhang. Methodology: Huilin Zhang, Mingyue Li, Xiaohan Zhang, Yang Li. Supervision: Guirong Zhang, Bing Han. Writing- original draft: Mingyue Li, Xiaohan Zhang, Yang Li. Writing-review & editing: Huilin Zhang, Guirong Zhang, Bing Han.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

We thank Rachel James for editing this manuscript. This research was funded by the Natural Science Foundation of Shandong Province (Grant No. ZR2020MH377).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BCA Protein Concentration
Measurement Kit
Beyotime BiotechnologyP0012S
Chemiluminescent imaging systemBeijing Sage Venture Technology Co.ChampChemi 910
Dopamine hydrochlorideSigma–AldrichPHR1090
Electronic balanceShanghai OHAUS Instrument Co.AR-2140
ELISA kits for IL-1βCOIBO BiotechnologyCB10018-FI
ELISA kits for TNF-αCOIBO BiotechnologyCB10148-FI
GAPDH antibodyCell Signaling Technology5174S
GraphPad Prism 5.0GraphPad statistical Software, Boston,
MA, USA, www.graphpad.com
Prism 5.0
High-performance liquid
chromatography–electrochemical
detection (HPLC–ECD)
GL Sciences, Ibaraki, JapanED723
High-speed freezing centrifugeBeijing Dalong Xingchuang
Experimental Instrument Co.
D3024R
HPLC–ECDGL SciencesED723
HSYALuye Pharma Group Ltd.LY202206
Image QuantGE Healthcare, Tokyo, JapanLAS 4000
Lamin B1 antibodyCell Signaling Technology13435S
LPSSigma–AldrichL2630
MicroscopeLeica, WetzlarDM1000LED
MicroscopeLeica, GermanyDM1000LED
Multifunctional Enzyme LabelerShanghai Meigu Molecular Instrument Co.SpectraMax Paradigm
NF-κB antibodyCell Signaling Technology8242S
Noldus Visual Vision XT systemBeijing Noldus Biotechnology Co., Ltd.EthoVision XT15
Nuclear and Cytoplasmic
Protein Extraction Kit
Beyotime BiotechnologyP0028
PMSFBeyotime BiotechnologyST506
TAK-242Merck614316
ThermostatShenzhen Galaxy Instrumentation Co.12810129
TLR4 antibodyAbcamab13556
ZebrafishNorthern Center for National
Zebrafish Model Animals
AB strain
Zebrafish recirculating water systemBeijing Aisheng Biotechnology Co., Ltd.ESEN-AW-S1

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Lazdon, E., Stolero, N., Frenkel, D. Microglia and Parkinson's disease: Footprints to pathology. J Neural Transm. 127 (2), 149-158 (2020).
  2. Block, M. L., Zecca, L., Hong, J. S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci. 8 (1), 57-69 (2007).
  3. Wang, A., et al. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway. Neuropharmacology. 257, 110063(2024).
  4. Dhureja, M., Deshmukh, R. Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents. Eur J Pharmacol. 975, 176635(2024).
  5. Jiang, S. Y., et al. Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury. EMBO Rep. 24 (10), e57101(2023).
  6. Lal, R., et al. Experimental models of Parkinson's disease: Challenges and Opportunities. Eur J Pharmacol. 980, Article 176819 (2024).
  7. Wang, T., et al. Hydroxysafflor Yellow A attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation in primary mesencephalic cultures. Molecules. 23 (5), 1210(2018).
  8. Yang, X., et al. Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways. Pharm Biol. 58 (1), 686-694 (2020).
  9. Feng, X., et al. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice. Phytomedicine. 112, 154684(2023).
  10. Liu, S., et al. Hydroxysafflor yellow A inhibits TNF-α-induced inflammation of human fetal lung fibroblasts via NF-κB signaling pathway. Evid Based Complement Alternat Med. 2019, 4050327(2019).
  11. Liang, L., et al. Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes. Int J Ophthalmol. 12 (11), 1699-1707 (2019).
  12. Zhao, Y., et al. Rosmarinic acid protects against MPTP-induced dopaminergic neurotoxicity in zebrafish embryos. Toxicol In Vitro. 65, 104823(2020).
  13. Monje, M. L., Toda, H., Palmer, T. D. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 302 (5651), 1760-1765 (2003).
  14. Batiha, G. E., et al. Commiphora myrrh: A phytochemical and pharmacological update. Naunyn Schmiedebergs Arch Pharmacol. 396 (3), 405-420 (2023).
  15. Al-Kuraishy, H. M., et al. Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night. CNS Neurosci Ther. 30 (3), e14521(2024).
  16. Alrouji, M., et al. Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective. Neuropsychopharmacol Rep. 44 (3), 639-649 (2024).
  17. Jankovic, J. Parkinson's disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 79, 368-376 (2008).
  18. Al-Kuraishy, H. M., et al. Parkinson's disease risk and hyperhomocysteinemia: The possible link. Cell Mol Neurobiol. 43 (6), 2743-2759 (2023).
  19. Al-Kuraishy, H. M., et al. The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon. Ageing Res Rev. 94, 102200(2024).
  20. Hou, S., et al. Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury. Exp Neurol. 285, 136-146 (2016).
  21. Kalia, L. V., Lang, A. E. Parkinson's disease. Lancet. 386, 896-912 (2015).
  22. Hirsch, E. C., Standaert, D. G. Ten unsolved questions about neuroinflammation in Parkinson's disease. Mov Disord. 36, 16-24 (2021).
  23. Hussey, S. E., et al. TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells. Biosci Rep. 33, e00098(2012).
  24. Heidari, A., Yazdanpanah, N., Rezaei, N. The role of Toll-like receptors and neuroinflammation in Parkinson's disease. J Neuroinflamm. 19, 135(2022).
  25. Zhao, Z., et al. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 9, 226(2021).
  26. Sun, M. F., Shen, Y. Q. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev. 45, 53-61 (2018).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Zebrafish ModelTLR4 SignalingNF KappaB PathwayParkinson s DiseaseNeuroinflammationDopamine LevelMotor Dysfunction
Video Coming Soon

Related Articles